SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-97-000733
Filing Date
1997-03-07
Accepted
1997-03-07 00:00:00
Documents
8
Period of Report
1996-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 GUILFORD PHARMACEUTICALS 10-K 10-K 236197
2 AMENDMENT TO OPTION PLAN EX-10.01.D 3145
3 LETTER DATED 4/2/96, AMEND. INS. AGREE. EX-10.31.B 2664
4 TERM LOAN, BETWEEN COMPANY AND SIGNET BANK EX-10.36 23402
5 COMPUTATION OF EARNINGS EX-11 1978
6 SUBSIDIARIES OF THE REGISTRANT EX-21 539
7 CONSENT OF KPMG PEAT MARWICK LLP EX-23.01 943
8 FINANCIAL DATA SCHEDULE EX-27 2073
  Complete submission text file 0000950133-97-000733.txt   273042
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23736 | Film No.: 97553053
SIC: 2834 Pharmaceutical Preparations